436 related articles for article (PubMed ID: 7465432)
1. [Quantitative whole-body bone scintigraphy. II. Pharmacokinetics of osteotropic radiopharmaceuticals (author's transl)].
Anger K; Aigner S; Bühler M; Umbach I
Nuklearmedizin; 1980 Jul; 19(3):97-107. PubMed ID: 7465432
[TBL] [Abstract][Full Text] [Related]
2. [Bayesian analysis of myocardial scintigraphy using 99mTc-Sn(II)-methylenediphosphonate and using 99mTc-Sn(II)-pyrophosphate].
Cuarón A; Acero A; Cárdenas M
Arch Inst Cardiol Mex; 1982; 52(5):365-72. PubMed ID: 7149857
[TBL] [Abstract][Full Text] [Related]
3. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
[TBL] [Abstract][Full Text] [Related]
4. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
Huckell VF; Lyster DM; Morrison RT; Cooper JA
Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
[TBL] [Abstract][Full Text] [Related]
5. 99mTc bone scanning agents--IV. Chemical characterization of 99mTc(Sn)-pyrophosphate complexes.
Kroesbergen J; Roozen AM; Gelsema WJ; de Ligny CL
Int J Rad Appl Instrum B; 1988; 15(2):209-14. PubMed ID: 3366621
[TBL] [Abstract][Full Text] [Related]
6. [Bone scintigraphy with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) (author's transl)].
Okahashi S; Ishimaru T; Maeda H; Sakata T; Yamasaki K; Akagi H
Radioisotopes; 1981 Aug; 30(8):458-60. PubMed ID: 7335921
[No Abstract] [Full Text] [Related]
7. 99mTc bone scanning agents--VI. Gel chromatographic analysis of the plasma protein binding of 99mTc(Sn)pyrophosphate, 99mTc(Sn)MDP and 99mTc(Sn)HMDP.
Kroesbergen J; Roozen AM; Wortelboer MR; Gelsema WJ; de Ligny CL
Int J Rad Appl Instrum B; 1988; 15(5):479-87. PubMed ID: 3254872
[No Abstract] [Full Text] [Related]
8. [Whole body bone scintigram with 99mTc-HMDP (technetium-99m-hydroxy methylene diphosphonate) (author's transl)].
Isobe Y; Ko S; Umegaki Y; Takahashi S; Kawaguchi N; Wada S; Matsumoto S
Radioisotopes; 1981 Nov; 30(11):606-8. PubMed ID: 7335900
[No Abstract] [Full Text] [Related]
9. [Comparative studies on 99mTc-pyrophosphate and 85Sr-chloride for skeletal imaging].
Sato T; Yamaura H; Okuyama S; Matsuzawa T
Radioisotopes; 1984 Apr; 33(4):207-12. PubMed ID: 6089270
[TBL] [Abstract][Full Text] [Related]
10. [Bone scintigraphy with 99mTc-hydroxymethylene diphosphonate (HMDP)--comparison with 99mtc-MDP (author's transl)].
Nakano S; Hasegawa Y; Shiomura K; Ibuka K; Hashizume T
Kaku Igaku; 1981 Dec; 18(10):1485-8. PubMed ID: 6210789
[No Abstract] [Full Text] [Related]
11. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
[TBL] [Abstract][Full Text] [Related]
13. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)].
Honda H; Oshiumi Y; Kamoi I; Ichiya Y; Wada M; Matsuura K
Kaku Igaku; 1981 Nov; 18(9):1315-9. PubMed ID: 6461790
[No Abstract] [Full Text] [Related]
15. [Radiochemical purity and stability of 99mTc-MDP for bone scintigraphy (author's transl)].
Yoshino T; Watanabe N; Kawahara Y; Okada K; Nishimura I
Radioisotopes; 1980 Aug; 29(8):398-400. PubMed ID: 6451900
[No Abstract] [Full Text] [Related]
16. 99mTc bone scanning agents--I. Influence of experimental conditions on the formation and gel chromatography of 99mTc(Sn)pyrophosphate complexes.
Kroesbergen J; Gelsema WJ; De Ligny CL
Int J Nucl Med Biol; 1985; 12(2):83-8. PubMed ID: 2995268
[TBL] [Abstract][Full Text] [Related]
17. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat.
Watt I; Hill P
Br J Radiol; 1981 Jul; 54(643):592-6. PubMed ID: 6455174
[TBL] [Abstract][Full Text] [Related]
19. [Bone scintigraphy with 99mTc-labeled methylene diphosphonate in hemodialysis patients (author's transl)].
Yamashita M; Aoki T; Kakiuchi T; Mabuchi H; Tabata Y; Murao Y; Nishizawa H; Maruyama Y; Kishi Y; Nakahashi H; Murakami K
Radioisotopes; 1981 Nov; 30(11):609-11. PubMed ID: 6461029
[No Abstract] [Full Text] [Related]
20. [Horseshoe kidney incidentally detected by 99mTc-MDP bone scintigraphy: report of 2 cases (author's transl)].
Bussaka H; Takahashi M
Rinsho Hoshasen; 1982 May; 27(5):581-3. PubMed ID: 6213796
[No Abstract] [Full Text] [Related]
[Next] [New Search]
